Journey DX, a patient research company, is working with patient advocacy group Canadian Skin Patient Alliance to better understand the patient journey for melanoma, the impact of this disease, and treatment options that have provided benefit.
We are conducting telephone focus groups for Canadians with advanced melanoma, and their caregivers. We would especially like to hear the perspective of those who have been enrolled in a pembrolizumab trial (or care for a patient who has), to understand patient/caregiver experience with this drug, and how it may affect quality of life. The results of the focus groups will be shared with all patient advocacy organizations in Canada, and may support healthcare decision-making for those with melanoma.
The focus groups will last approximately one hour, and will be conducted over the telephone to be comfortable and convenient for patients and caregivers who would like to share their experiences.
A compensation of $50 will be provided to those who participate, in appreciation of their time.
If you would like to be involved or would simply like more information, please contact Dr. Jennifer Pereira, Research Director of Journey DX (firstname.lastname@example.org, 416-485-7387).
Thank you for your consideration.
Viewing 1 post (of 1 total)
The forum ‘Melanoma Diagnosis: Stage IV’ is closed to new topics and replies.